Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2021 | 1 |
2023 | 5 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review.
Subst Abuse Treat Prev Policy. 2023 Sep 30;18(1):56. doi: 10.1186/s13011-023-00564-9.
Subst Abuse Treat Prev Policy. 2023.
PMID: 37777766
Free PMC article.
Review.
Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review.
Adams A, Blawatt S, MacDonald S, Finnick R, Lajeunesse J, Harrison S, Byres D, Schechter MT, Oviedo-Joekes E.
Adams A, et al. Among authors: lajeunesse j.
Int J Drug Policy. 2023 Jul;117:104058. doi: 10.1016/j.drugpo.2023.104058. Epub 2023 May 8.
Int J Drug Policy. 2023.
PMID: 37182352
Free PMC article.
Review.
Item in Clipboard
Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study.
Oviedo-Joekes E, Dobischok S, Carvajal J, MacDonald S, McDermid C, Klakowicz P, Harrison S, LaJeunesse J, Chow N, Brown M, Gill S, Schechter M.
Oviedo-Joekes E, et al. Among authors: lajeunesse j.
BMC Health Serv Res. 2023 May 26;23(1):553. doi: 10.1186/s12913-023-09558-6.
BMC Health Serv Res. 2023.
PMID: 37237256
Free PMC article.
Item in Clipboard
"As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crises.
Jaffe K, Blawatt S, Lehal E, Lock K, Easterbrook A, MacDonald S, Harrison S, Lajeunesse J, Byres D, Schechter M, Oviedo-Joekes E.
Jaffe K, et al. Among authors: lajeunesse j.
Harm Reduct J. 2023 Apr 14;20(1):51. doi: 10.1186/s12954-023-00779-w.
Harm Reduct J. 2023.
PMID: 37060027
Free PMC article.
Item in Clipboard
The Impact of Injectable Opioid Agonist Treatment (iOAT) on Involvement in Criminalized Activities: A Secondary Analysis from a Clinical Trial in Vancouver, BC.
Dobischok S, Guh D, Marchand K, MacDonald S, Lock K, Harrison S, Lajeunesse J, Schechter MT, Oviedo-Joekes E.
Dobischok S, et al. Among authors: lajeunesse j.
Subst Abuse Rehabil. 2023 Nov 15;14:147-156. doi: 10.2147/SAR.S438451. eCollection 2023.
Subst Abuse Rehabil. 2023.
PMID: 38026787
Free PMC article.
Item in Clipboard
How Can We Raise Awareness of Physician's Needs in Order to Increase Adherence to Management and Leadership Training?
Voirol C, Pelland MF, Lajeunesse J, Pelletier J, Duplain R, Dubois J, Lachance S, Lambert C, Sader J, Audetat MC.
Voirol C, et al. Among authors: lajeunesse j.
J Healthc Leadersh. 2021 Apr 28;13:109-117. doi: 10.2147/JHL.S288199. eCollection 2021.
J Healthc Leadersh. 2021.
PMID: 33953630
Free PMC article.
Item in Clipboard
Collaboration between family physicians and nurse clinicians: opinions of graduates in family medicine.
Maheux B, Côté L, Sobanjo O, Authier L, Lajeunesse J, Leclerc M, Lefort L.
Maheux B, et al. Among authors: lajeunesse j.
Can Fam Physician. 2014 Aug;60(8):e416-22.
Can Fam Physician. 2014.
PMID: 25122832
Free PMC article.
Item in Clipboard
Cite
Cite